Sunflower Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 85.8% in First Quarter of 2023

Sunflower Pharmaceutical Group Co.,Ltd. (葵花药业集团股份有限公司) (002737.SZ) reported a net profit of 435.4 million yuan in the first quarter of 2023, up 85.8% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, up 47.3% year-on-year.

At the end of the reporting period, it had 7.1 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 31.4%.